B

Active Director Director DIN 09566754
DIN 09566754 First appointment Apr 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Babeeta

Data last updated:

Babeeta is a Director at Levere Healthcare Private Limited (since 2022). The company operates in Healthcare. Levere Healthcare Private Limited reported revenue of ₹64.5 Lakh (FY 2024).

DIN 09566754
Primary Designation Director
Industry Healthcare
First Appointment 09 Apr 2022
Oldest Company Age 4 yrs
Largest company Levere Healthcare Private Limited · ₹64.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Levere Healthcare Private Limited U85300UP2022PTC162120
Director09 Apr 20222022₹64.5 Lakh (FY 2024)Active

Board colleagues of Babeeta

NameDINCompanyDesignation
Tushar Vishnoi09566753Levere Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Levere Healthcare Private Limited
Premium access

Shareholding and investment profile for Babeeta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babeeta

Babeeta currently holds 1 directorship: Levere Healthcare Private Limited (Director, since 09 Apr 2022, revenue ₹64.5 Lakh (FY 2024)).

Babeeta was first appointed on 09 Apr 2022 as Director at Levere Healthcare Private Limited.

The current boards of Babeeta's companies include Tushar Vishnoi (Levere Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available